ECOLAB INC.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
ECL$306.03-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||
|---|---|---|
| (millions) | 2026 | 2025 |
| OPERATING ACTIVITIES | ||
| Net income including noncontrolling interest | $1,529.7 | $1,524.7 |
| Adjustments to reconcile net income to cash provided by operating activities: | ||
| Depreciation | 545.4 | 493.8 |
| Amortization | 273.9 | 226.5 |
| Deferred income taxes | 115.3 | (57.1) |
| Share-based compensation expense | 116.0 | 109.5 |
| Pension and postretirement plan contributions | (47.1) | (67.1) |
| Pension and postretirement plan (income) expense, net | 27.9 | 10.4 |
| Restructuring charges, net of cash paid | (24.6) | (12.5) |
| Sale of global surgical solutions business | - | 1.1 |
| Other, net | 53.2 | 20.4 |
| Changes in operating assets and liabilities, net of effect of acquisitions: | ||
| Accounts receivable | (457.1) | (150.3) |
| Inventories | (199.0) | (37.6) |
| Other assets | (219.1) | 34.1 |
| Accounts payable | 297.2 | (47.8) |
| Other liabilities | (72.6) | (185.6) |
| Cash provided by operating activities | 1,939.1 | 1,862.5 |
| INVESTING ACTIVITIES | ||
| Capital expenditures | (902.0) | (716.2) |
| Property and other assets sold | 2.3 | 46.4 |
| Acquisitions and investments in affiliates, net of cash acquired | (4,683.1) | (0.5) |
| Divestiture of businesses, net of cash divested | - | (14.9) |
| Other, net | (38.3) | (43.8) |
| Cash used for investing activities | (5,621.1) | (729.0) |
| FINANCING ACTIVITIES | ||
| Net (repayments) issuances of commercial paper and notes payable | (95.4) | 1.1 |
| Long-term debt borrowings | 5,104.9 | 1,019.0 |
| Long-term debt repayments | - | (674.2) |
| Reacquired shares | (672.1) | (374.6) |
| Dividends paid | (628.7) | (564.4) |
| Exercise of employee stock options | 108.9 | 182.0 |
| Deferred financing costs | (49.2) | - |
| Other, net | (13.4) | (10.6) |
| Cash provided by (used for) financing activities | 3,755.0 | (421.7) |
| Effect of exchange rate changes on cash and cash equivalents | 3.1 | (12.8) |
| Increase in cash and cash equivalents | 76.1 | 699.0 |
| Cash and cash equivalents, beginning of period | 646.2 | 1,256.8 |
| Cash and cash equivalents, end of period | $722.3 | $1,955.8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.